Moreover, although humans with CGD may have improved colitis following hematopoietic stem cell transplantation [19], there may be differences in either the intestinal microbiota or p47phox-NOX complex interactions in non-hematopoietic colonic cells, which may explain the species-specific differences in colitis remission post-bone marrow transplantation. This evidence concerns the gene NCF1 and colitis.